Aurora Cannabis Inc (NYSE:ACB) (TSX:ACB) announced Tuesday that it had secured an export permit and completed its first shipment of medical cannabis to the Czech Republic.

The first order was shipped to Czech Medical Herbs s.r.o., a Czech drug wholesaler, which will supply pharmacies across the country.

"The Czech Republic represents the 21st country in which we operate, and exemplifies how we are rapidly expanding our global footprint in the medical cannabis space,” said Neil Belot, chief global business development officer at Aurora Cannabis. “We look forward to building a long-term relationship with our customer, CMH, and supplying patients in the Czech Republic with our high-quality cannabis products."

Under the Czech medical program, patients are allowed up to 180 grams of dry flower product a month, as prescribed by specialized doctors. The medical program was launched in 2013.

The Czech Republic and its capital Prague are often called the Amsterdam of the East — the city is known for its high-quality cannabis.

Edmonton, Canada-based Aurora Cannabis produces and distributes medical cannabis products.

Aurora's US-listed shares were down 2.6% in morning trade on a broad market pullback.